The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2010

Filed:

Jul. 28, 2006
Applicants:

Horst Wähling, Huddinge, SE;

Bertil Samuelsson, Huddinge, SE;

Inventors:

Horst Wähling, Huddinge, SE;

Bertil Samuelsson, Huddinge, SE;

Assignee:

Medivir AB, Huddinge, SE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A01N 43/54 (2006.01); A61K 31/517 (2006.01); A61K 31/47 (2006.01); C07D 401/00 (2006.01); C07D 403/00 (2006.01); C07D 413/00 (2006.01); C07D 417/00 (2006.01); C07D 419/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of the formula (I): and N-oxides, salts and stereoisomers thereof wherein A is OR, NHS(═O)R, NHR, NRaRb, C(═O)NHRor C(═O)NRaRb wherein; Ris hydrogen, C-Calkyl, C-Calkylenecarbocyclyl, C-Calkyleneheterocyclyl; Ris C-Calkyl, C-Calkylenecarbocyclyl, C-Calkyleneheterocyclyl or NRaRb; Ris C-Calkyl, C-Calkylenecarbocyclyl, C-Calkyleneheterocyclyl, —OC-Calkyl, —OC-Calkylenecarbocyclyl, —OC-Calkyleneheterocyclyl; wherein any alkyl, carbocyclyl or heterocycylyl in R, Ror Rare optionally substituted p is independently 1 or 2; n is 3, 4, 5 or 6; denotes an optional double bond; Rq is H or when L is CRz, Rq can also be C-Calkyl; Ry and Ry' are independently C-Calkyl; L is N or CRz; Rz is H or forms a double bond with the asterisked carbon; W is —CH—, —O—, —OC(═O)NH—, —OC(═O)—, —S—, —NH—, —NRa, —NHS(═O)—, —NHC(=0)NH— or —NHC(═O)—, —NHC(═S)NH— or a bond; Ris an optionally substituted ring system containing 1 or 2 saturated, partially saturated or unsaturated carbo or heterocyclic rings have utility in the inhibition of NS-3 serine proteases, such as flavivirus infections.


Find Patent Forward Citations

Loading…